Prognostic Value of Vimentin in Triple Negative Breast Cancer Patients Depends on Chemotherapy Regimen and p53 Mutant Expression.

Ibnu Purwanto Benedreky Leo Susanna Hilda HutajuluJohan KurniandaKartika Widayati Taroeno-HariadiMardiah Suci HardiantiAmanda Dania SatitiEry Kus DwianingsihDidik Setyo HeriyantoIrianiwati WidodoTeguh Aryandono

Published in: Breast cancer (Dove Medical Press) (2023)

Vimentin expression was independently associated with improved 48-month OS in TNBC patients treated with non-platinum-based chemotherapy. Expression of p53 mutant significantly affected the prognostic value of vimentin.

Keyphrases

poor prognosis
binding protein
locally advanced
long non coding rna
squamous cell carcinoma
radiation therapy